Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203.

Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW.

J Clin Oncol. 2018 Aug 20;36(24):2538-2544. doi: 10.1200/JCO.2017.77.4273. Epub 2018 Jul 10.

PMID:
29989857
2.

Values and worries of ovarian cancer patients.

Pisu M, Kenzik KM, Rim SH, Funkhouser EM, Bevis KS, Alvarez RD, Cantuaria G, Rocconi RP, Martin MY.

Gynecol Oncol. 2017 Nov;147(2):433-438. doi: 10.1016/j.ygyno.2017.08.028. Epub 2017 Sep 7.

3.

Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells.

Mittal K, Choi DH, Ogden A, Donthamsetty S, Melton BD, Gupta MV, Pannu V, Cantuaria G, Varambally S, Reid MD, Jonsdottir K, Janssen EA, Aleskandarany MA, Ellis IO, Rakha EA, Rida PC, Aneja R.

Sci Rep. 2017 Mar 8;7:43984. doi: 10.1038/srep43984.

4.

Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer.

Ogden A, Garlapati C, Li XB, Turaga RC, Oprea-Ilies G, Wright N, Bhattarai S, Mittal K, Wetherilt CS, Krishnamurti U, Reid MD, Jones M, Gupta M, Osan R, Pattni S, Riaz A, Klimov S, Rao A, Cantuaria G, Rida PC, Aneja R.

Sci Rep. 2017 Feb 20;7:42289. doi: 10.1038/srep42289.

5.

Preclinical Development of a Nontoxic Oral Formulation of Monoethanolamine, a Lipid Precursor, for Prostate Cancer Treatment.

Saxena R, Yang C, Rao M, Turaga RC, Garlapati C, Gundala SR, Myers K, Ghareeb A, Bhattarai S, Kamalinia G, Bristi S, Su D, Gadda G, Rida PCG, Cantuaria GH, Aneja R.

Clin Cancer Res. 2017 Jul 15;23(14):3781-3793. doi: 10.1158/1078-0432.CCR-16-1716. Epub 2017 Feb 6.

6.

Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations.

Wright N, Xia J, Cantuaria G, Klimov S, Jones M, Neema P, Il'yasova D, Krishnamurti U, Li X, Reid MD, Gupta M, Rida PC, Osan R, Aneja R.

PLoS One. 2017 Jan 13;12(1):e0170095. doi: 10.1371/journal.pone.0170095. eCollection 2017.

7.

A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.

Mittal K, Choi DH, Klimov S, Pawar S, Kaur R, Mitra AK, Gupta MV, Sams R, Cantuaria G, Rida PCG, Aneja R.

J Ovarian Res. 2016 Mar 18;9:17. doi: 10.1186/s13048-016-0224-0.

8.

How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity.

Rida PC, Cantuaria G, Reid MD, Kucuk O, Aneja R.

Cancer Metastasis Rev. 2015 Dec;34(4):703-13. doi: 10.1007/s10555-015-9590-0. Review.

9.

Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers.

Pannu V, Mittal K, Cantuaria G, Reid MD, Li X, Donthamsetty S, McBride M, Klimov S, Osan R, Gupta MV, Rida PC, Aneja R.

Oncotarget. 2015 Apr 30;6(12):10487-97.

10.

HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients.

Pannu V, Rida PC, Ogden A, Turaga RC, Donthamsetty S, Bowen NJ, Rudd K, Gupta MV, Reid MD, Cantuaria G, Walczak CE, Aneja R.

Oncotarget. 2015 Mar 20;6(8):6076-91.

11.

Epithelial ovarian cancer: An overview.

Desai A, Xu J, Aysola K, Qin Y, Okoli C, Hariprasad R, Chinemerem U, Gates C, Reddy A, Danner O, Franklin G, Ngozi A, Cantuaria G, Singh K, Grizzle W, Landen C, Partridge EE, Rice VM, Reddy ES, Rao VN.

World J Transl Med. 2014 Apr 12;3(1):1-8.

12.

Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells.

Pannu V, Rida PC, Celik B, Turaga RC, Ogden A, Cantuaria G, Gopalakrishnan J, Aneja R.

Cell Death Dis. 2014 Nov 20;5:e1538. doi: 10.1038/cddis.2014.505.

13.

Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics.

Mukkavilli R, Gundala SR, Yang C, Donthamsetty S, Cantuaria G, Jadhav GR, Vangala S, Reid MD, Aneja R.

PLoS One. 2014 Sep 24;9(9):e108386. doi: 10.1371/journal.pone.0108386. eCollection 2014.

14.

KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries.

Pawar S, Donthamsetty S, Pannu V, Rida P, Ogden A, Bowen N, Osan R, Cantuaria G, Aneja R.

J Ovarian Res. 2014 May 12;7:53. doi: 10.1186/1757-2215-7-53. eCollection 2014.

15.

Continent urinary diversion and low colorectal anastomosis after pelvic exenteration. Quality of life and complication risk.

Angioli R, Panici PB, Mirhashemi R, Mendez L, Cantuaria G, Basile S, Penalver M.

Crit Rev Oncol Hematol. 2003 Dec;48(3):281-5. Review.

PMID:
14693340
16.

Expression of glucose transporter-1 in cervical cancer and its precursors.

Mendez LE, Manci N, Cantuaria G, Gomez-Marin O, Penalver M, Braunschweiger P, Nadji M.

Gynecol Oncol. 2002 Aug;86(2):138-43.

PMID:
12144819
17.

GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy.

Cantuaria G, Fagotti A, Ferrandina G, Magalhaes A, Nadji M, Angioli R, Penalver M, Mancuso S, Scambia G.

Cancer. 2001 Sep 1;92(5):1144-50.

PMID:
11571727
18.

Evaluation of the Pfannenstiel incision for radical abdominal hysterectomy with pelvic and para-aortic lymphadenectomy.

Mendez LE, Cantuaria G, Angioli R, Mirhashemi R, Gabriel C, Estape R, Penalver M.

Int J Gynecol Cancer. 1999 Sep;9(5):418-420.

PMID:
11240804
19.

Radical hysterectomy for cervical cancer: hysterectomy before pelvic lymphadenectomy or vice versa?

Angioli R, Estape R, Salom E, Cantuaria G, Mirhashemi R, Mendez L, Yoo R, Penalver M.

Int J Gynecol Cancer. 1999 Jul;9(4):307-311.

PMID:
11240784
20.

Low colorectal anastomosis after radical pelvic surgery: a risk factor analysis.

Mirhashemi R, Averette HE, Estape R, Angioli R, Mahran R, Mendez L, Cantuaria G, Penalver M.

Am J Obstet Gynecol. 2000 Dec;183(6):1375-9; discussion 1379-80.

PMID:
11120499
21.

Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary.

Cantuaria G, Magalhaes A, Penalver M, Angioli R, Braunschweiger P, Gomez-Marin O, Kanhoush R, Gomez-Fernandez C, Nadji M.

Gynecol Oncol. 2000 Oct;79(1):33-7.

PMID:
11006027
22.

Primary malignant melanoma of the uterine cervix: case report and review of the literature.

Cantuaria G, Angioli R, Fernandez-Abril A, Penalver M.

Prim Care Update Ob Gyns. 1998 Jul 1;5(4):159-160.

PMID:
10838297
23.

Severe perineal lacerations during vaginal delivery: the University of Miami experience.

Angioli R, Gómez-Marín O, Cantuaria G, O'sullivan MJ.

Am J Obstet Gynecol. 2000 May;182(5):1083-5.

PMID:
10819834
24.

Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma.

Cantuaria G, Magalhaes A, Angioli R, Mendez L, Mirhashemi R, Wang J, Wang P, Penalver M, Averette H, Braunschweiger P.

Cancer. 2000 Jan 15;88(2):381-8.

PMID:
10640972
25.

Primary malignant melanoma of the uterine cervix: case report and review of the literature.

Cantuaria G, Angioli R, Nahmias J, Estape R, Penalver M.

Gynecol Oncol. 1999 Oct;75(1):170-4. Review.

PMID:
10502448
26.

Urinary complications of Miami pouch: trend of conservative management.

Angioli R, Estape R, Cantuaria G, Mirhashemi R, Williams H, Martin J, Penalver M.

Am J Obstet Gynecol. 1998 Aug;179(2):343-8.

PMID:
9731836
27.

Comparison of bimanual examination with ultrasound examination before hysterectomy for uterine leiomyoma.

Cantuaria GH, Angioli R, Frost L, Duncan R, Penalver MA.

Obstet Gynecol. 1998 Jul;92(1):109-12.

PMID:
9649104
28.

Spontaneous left tubal and right interstitial pregnancy. A case report.

Messore M, Angioli R, Cantuaria G, Penalver M.

J Reprod Med. 1997 Jul;42(7):445-7.

PMID:
9252937
29.

Gestational trophoblastic disease in a fifty-one year old woman.

Cantuaria G, Angioli R, Messore M, Estape R, Penalver M.

Oncol Rep. 1997 Jan-Feb;4(1):149-51.

PMID:
21590031

Supplemental Content

Loading ...
Support Center